uniQure N.V. - stock earnings
QURE Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| April 29, 2024 BeforeMarket | - / -1.3056000000 | - | - / 6.4 million | - |
QURE Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -73.2 million USD | 6.7 million USD |
| 2023Q3 | -89.6 million USD | 1.4 million USD |
| 2023Q2 | -68.5 million USD | 2.4 million USD |
| 2023Q1 | -77.2 million USD | 5.3 million USD |
| 2022Q4 | 6.8 million USD | 102.7 million USD |
| 2022Q3 | -47.9 million USD | 1.4 million USD |
| 2022Q2 | -39.1 million USD | 497000 USD |
| 2022Q1 | -46.7 million USD | 1.8 million USD |
| 2021Q4 | 8.2 million USD | 57.7 million USD |
| 2021Q3 | -36.5 million USD | 2.0 million USD |
| 2021Q2 | 399.5 million USD | 463.9 million USD |
| 2021Q1 | -41.6 million USD | 454000 USD |
| 2020Q4 | -699000 USD | 34.1 million USD |
| 2020Q3 | -53.8 million USD | 1.8 million USD |
| 2020Q2 | -42.6 million USD | 1.5 million USD |
| 2020Q1 | -28.0 million USD | 104000 USD |
| 2019Q4 | -41.4 million USD | 2.6 million USD |
| 2019Q3 | -23.6 million USD | 1.0 million USD |
| 2019Q2 | -31.4 million USD | 2.5 million USD |
| 2019Q1 | -27.8 million USD | 1.1 million USD |
| 2018Q4 | -21.9 million USD | 1.6 million USD |
| 2018Q3 | -22.0 million USD | 3.1 million USD |
| 2018Q2 | -20.6 million USD | 3.1 million USD |
| 2018Q1 | -18.8 million USD | 3.5 million USD |
| 2017Q4 | -27.5 million USD | 2.6 million USD |
| 2017Q3 | -10.2 million USD | 2.3 million USD |
| 2017Q2 | -21.3 million USD | 4.9 million USD |
| 2017Q1 | -20.3 million USD | 3.3 million USD |
| 2016Q4 | -13.4 million USD | 9.0 million USD |
| 2016Q3 | -15.2 million USD | 7.3 million USD |
| 2016Q2 | -21.5 million USD | 4.4 million USD |
| 2016Q1 | -13.6 million USD | 3.7 million USD |
| 2015Q4 | -13.6 million USD | 3.7 million USD |
| 2015Q3 | -29.1 million USD | 3.5 million USD |
| 2015Q2 | -21.2 million USD | 1.8 million USD |
| 2015Q1 | -12.2 million USD | 1.6 million USD |
| 2014Q4 | -12.2 million USD | 1.6 million USD |
| 2014Q3 | -11.5 million USD | 1.3 million USD |
| 2014Q2 | -12.3 million USD | 1.4 million USD |
| 2014Q1 | -9.5 million USD | 1.3 million USD |
| 2013Q4 | -9.5 million USD | 1.3 million USD |
| 2013Q3 | -9.5 million USD | 1.7 million USD |
| 2013Q2 | -10.1 million USD | 986157 USD |
| 2013Q1 | -6.6 million USD | ? USD |
| 2012Q4 | -6.1 million USD | ? USD |
| 2012Q3 | -4.6 million USD | ? USD |
QURE Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -308.5 million USD | 15.8 million USD |
| 2022 | -126.8 million USD | 106.5 million USD |
| 2021 | 329.6 million USD | 524.0 million USD |
| 2020 | -125.0 million USD | 37.5 million USD |
| 2019 | -128.0 million USD | 7.3 million USD |
| 2018 | -83.3 million USD | 11.3 million USD |
| 2017 | -80.4 million USD | 13.1 million USD |
| 2016 | -73.4 million USD | 25.1 million USD |
| 2015 | -78.1 million USD | 10.3 million USD |
| 2014 | -45.0 million USD | 5.7 million USD |
| 2013 | -37.0 million USD | 4.1 million USD |
| 2012 | -19.5 million USD | ? USD |
| 2011 | -22.4 million USD | ? USD |
QURE
Price: $4.53
52 week price:
Earnings Per Share: -6.47 USD
P/E Ratio: -1.11
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 380100
Ebitda: -8.2 millionMarket Capitalization: 228.7 million